Vera Liang
Psychiatry · Melville, NYNPI 1215002761
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 377 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,041 and has fallen 50.0% since, to $1,520 in 2025. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 377 payments — averaging $32.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Alkermes, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Lundbeck LLC$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Axsome Therapeutics, Inc.$679
- plus $4K from 15 others
What the payments were for
- Food & beverage$12,126100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $2,015 |
| Alkermes, Inc. | 49 | $1,959 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 46 | $1,211 |
| Lundbeck LLC | 56 | $1,081 |
| Otsuka America Pharmaceutical, Inc. | 36 | $1,039 |
| Axsome Therapeutics, Inc. | 14 | $679 |
| Neurocrine Biosciences, Inc. | 22 | $645 |
| Teva Pharmaceuticals USA, Inc. | 13 | $599 |
| Vanda Pharmaceuticals Inc. | 19 | $588 |
| Sunovion Pharmaceuticals Inc. | 13 | $584 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $499 |
| E.r. Squibb & Sons, L.L.C. | 4 | $307 |
| Johnson & Johnson | 3 | $270 |
| Supernus Pharmaceuticals, Inc. | 7 | $147 |
| Corium, LLC | 6 | $145 |
| Ironshore Pharmaceuticals Inc. | 1 | $125 |
| Eisai Inc. | 4 | $89 |
| Idorsia Pharmaceuticals US Inc | 3 | $67 |
| Alfasigma USA, Inc. | 2 | $42 |
| Noven Pharmaceuticals, Inc. | 1 | $21 |
| Adlon Therapeutics L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,925
- VRAYLAR$1,111
- ARISTADA$953
- Auvelity$372
- LATUDA$366
- CAPLYTA$257
- REXULTI$247
- ARISTADA INITIO$238
- AUSTEDO$136
- COBENFY$125
- SPRAVATO$125
- JORNAY PM$125
- Austedo XR$122
- UZEDY$120
- INVEGA SUSTENNA$115
- INVEGA TRINZA$115
- Fanapt$112
- ABILIFY ASIMTUFII$108
- ABILIFY MAINTENA$108
- INGREZZA$103
How this compares
$12,126 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 27 | $590 |
| Bupropion XlBupropion Hcl | 19 | $581 |
| Doxepin Hcl | 24 | $493 |
| Duloxetine Hcl | 13 | $423 |
| Aripiprazole | 13 | $269 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 33 | $263 |
| Paroxetine Hcl | 22 | $170 |
| Fluoxetine Hcl | 21 | $165 |
| Alprazolam | 27 | $132 |
| Quetiapine Fumarate | 17 | $97 |
| Sertraline Hcl | 11 | $89 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Melville
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.